XML 29 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 25, 2022
Dec. 26, 2021
Cash flows from operating activities:      
Net loss $ (113,384) $ (190,441) $ (153,175)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 59,491 46,471 35,549
Amortization of lease acquisition costs 92 93 402
Amortization of loan origination fees 55 126 95
Amortization of cloud computing arrangements 880 224 0
Operating lease cost 29,113 28,447 0
Loss on disposal of property and equipment 687 278 107
Stock-based compensation 49,532 78,736 28,897
Impairment and closure costs 90 2,542 4,915
Non-cash restructuring charges 5,281 13,026 0
Deferred income tax expense 358 1,290 125
Change in fair value of contingent consideration 3,475 819 4,037
Change in fair value of preferred stock warrant liability 0 0 14,955
Changes in operating assets and liabilities:      
Account receivable (258) (600) (1,557)
Tenant improvement receivables 0 0 (11,172)
Inventory (686) (480) (283)
Prepaid expenses and other current assets (3,789) (2,637) (8,375)
Operating lease liabilities (22,290) (13,955) 0
Accounts payable 9,871 (4,546) 3,045
Accrued payroll and benefits 6,551 (8,013) 2,829
Accrued expenses 1,163 5,732 (1,555)
Gift card and loyalty liability 781 177 (498)
Other non-current liabilities (533) (458) 0
Deferred rent liability 0 0 17,130
Net cash provided by (used in) operating activities 26,480 (43,169) (64,529)
Cash flows from investing activities:      
Purchase of property and equipment (89,672) (96,889) (84,511)
Purchase of intangible assets (6,115) (5,376) (8,264)
Acquisition, net of cash acquired 0 0 (3,340)
Security and landlord deposits 122 242 253
Lease acquisition costs 0 0 (1,686)
Net cash used in investing activities (95,665) (102,023) (97,548)
Cash flows from financing activities:      
Proceeds from preferred stock issuance, net of issuance costs 0 0 113,811
Proceeds from stock option exercise 5,388 4,758 26,028
Payment of contingent consideration (10,421) 0 0
Payment of loan origination fees 0 (126) 0
Proceeds from exercise of common stock warrants 0 0 119
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs 0 0 384,692
Payment associated to shares repurchased for tax withholding (166) 0 0
Proceeds from issuance of Series F warrants in connection with the initial public offering 0 0 1,803
Proceeds from related party loan 0 0 5,158
Net cash (used in) provided by financing activities (5,199) 4,632 531,611
Net (decrease) increase in cash and cash equivalents and restricted cash (74,384) (140,560) 369,534
Cash and cash equivalents and restricted cash—beginning of year 331,739 472,299 102,765
Cash and cash equivalents and restricted cash—end of year 257,355 331,739 472,299
Supplemental disclosure of cash flow:      
Cash paid for interest 50 0 0
Non-cash investing and financing activities:      
Purchase of property and equipment accrued in accounts payable and accrued expenses 6,824 7,980 2,389
Acquisition non-cash consideration 0 0 30,704
Initial liability associated with contingent consideration 0 0 16,440
Conversion of redeemable convertible preferred stock to common stock in connection with public company offering 0 0 614,496
Series F warrants      
Non-cash investing and financing activities:      
Reclassification of warrant liability to APIC in connection with initial public offering 0 0 6,580
Series J Warrants      
Non-cash investing and financing activities:      
Reclassification of warrant liability to APIC in connection with initial public offering $ 0 $ 0 $ 16,979